Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative 18F-FDG PET/CT: Don't Forget the Thyroid!

Curr Oncol. 2021 Aug 5;28(4):2987-2992. doi: 10.3390/curroncol28040261.

Abstract

Serum carcinoembryonic antigen (CEA) is a tumor marker especially used to follow a patient with colorectal cancer. However, it is non-specific and could be increased in several cancers and some benign conditions. We report the case of a 70-year-old man followed since 2014 for a left colon adenocarcinoma with the persistence of an increased CEA. There was no evidence of recurrence, but a right lobar thyroid nodule without a significantly increased uptake was incidentally discovered on the CT scan of 18F-fluorodeoxyglucose (18F-FDG) PET/CT. We suspected a medullary thyroid carcinoma (MTC) explaining the persistent elevation of CEA. Plasma calcitonin levels were 47 ng/L (N < 10). Fine needle aspiration cytology found atypia of undetermined significance and the patient was reluctant to undergo surgery without any further exploration. We performed a 18F-fluorodihydroxyphenylalanine (18F-FDOPA) PET/CT preoperatively which revealed a punctiform focus of the right thyroid lobe corresponding to a pT1aN1aMxR0 medullary thyroid carcinoma, histopathologically confirmed. This case highlights that despite the potential usefulness of 18F-FDG PET/CT in case of an unknown source of elevated CEA this imaging may be falsely negative as in the case of MTC and should lead to further explorations.

Keywords: calcitonin; carcinoembryonic antigen; colon adenocarcinoma; medullary thyroid carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Calcitonin
  • Carcinoembryonic Antigen
  • Colonic Neoplasms* / diagnostic imaging
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Positron Emission Tomography Computed Tomography
  • Thyroid Gland

Substances

  • Carcinoembryonic Antigen
  • Fluorodeoxyglucose F18
  • Calcitonin